AI
Monday, July 21, 2008 5:31:30 AM
Roche offers to buy out Genentech DNA for $43.7 billion
Roche, which already owns 55.9 percent of Genentech, said on Monday it would offer $89 per share to buy up the remaining stake, a 9 percent premium to the biotech company's closing share price on Friday.
My posting is for my own entertainment, do your own DD before pushing your buy/call button
Roche, which already owns 55.9 percent of Genentech, said on Monday it would offer $89 per share to buy up the remaining stake, a 9 percent premium to the biotech company's closing share price on Friday.
My posting is for my own entertainment, do your own DD before pushing your buy/call button
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
